This neuro-technology company specializes in spinal cord stimulation for chronic pain and neurological disorders, utilizing a precise lead positioning system within the intrathecal space. By eliminating the need for opioids, their technology enhances treatment efficacy and improves patient outcomes.
Funding
$820K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Conventional epidural spinal cord stimulation (SCS) for chronic pain often lacks efficacy due to energy loss and limited reach to deeper axons, leading to inconsistent pain relief and patient discomfort. Existing SCS devices consume significant energy without effectively targeting the spinal cord, and require frequent recharging, impacting patient quality of life. The opioid epidemic highlights the urgent need for effective, non-opioid alternatives for chronic pain management.
Solution
Spinally Medical is developing an intrathecal spinal cord stimulation (iSCS) system designed to overcome the limitations of traditional epidural SCS. The FuturaLead™ is an ultra-thin lead designed for precise placement within the intrathecal space, directly on the spinal cord surface. By eliminating tissue barriers and leveraging the conductivity of cerebrospinal fluid, the iSCS system delivers targeted stimulation with significantly reduced energy loss. This approach allows for stimulation of deeper axons, enhancing treatment efficacy and providing more consistent pain relief. The FuturaLead™ also enables high-quality neural signal recording, facilitating personalized closed-loop therapy based on real-time feedback from the spinal cord.
Target Audience
The primary target audience includes patients suffering from chronic pain, anesthesiologists, pain management specialists, and medical professionals seeking effective, non-opioid alternatives to traditional spinal cord stimulation.
Features
- FuturaLead™: An ultra-thin, minimally invasive lead for intrathecal implantation
- Precise lead positioning system for targeted stimulation of the spinal cord
- Enhanced energy efficiency, minimizing energy loss and maximizing therapeutic effect
- Ability to stimulate deeper layers of the spinal cord compared to traditional epidural SCS
- High-quality neural signal recording capabilities for personalized, closed-loop therapy
- Measurement of Evoked Compound Action Potentials (ECAPs) for real-time feedback and treatment optimization
- Percutaneous insertion for less invasive implantation